Literature DB >> 25454732

Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy.

Roberto De Sanctis1, Marika Pane1, Serena Sivo1, Valeria Ricotti2, Giovanni Baranello3, Silvia Frosini4, Elena Mazzone1, Flaviana Bianco1, Lavinia Fanelli1, Marion Main2, Alice Corlatti3, Adele D'Amico5, Giulia Colia5, Roberta Scalise1, Concetta Palermo1, Chiara Alfonsi1, Giovanna Tritto1, Domenico M Romeo1, Alessandra Graziano1, Roberta Battini4, Lucia Morandi3, Enrico Bertini5, Francesco Muntoni2, Eugenio Mercuri6.   

Abstract

The aim of this study was to establish the suitability of the North Star Ambulatory Assessment for use in young boys with Duchenne muscular dystrophy. We studied 147 typically developing and 144 boys affected by Duchenne muscular dystrophy between the ages of 3 and 5 years. More than 85% of the typically developing boys by the age of 4 years had full scores on all the items with total scores ≥33/34. Before the age of 4 years more than 15% of the typically developing boys did not achieve full scores on all the items. Some items, such as standing on one leg, showed significant improvement with age. In contrast, other activities were rarely achieved even in the older boys. Even if there was a progressive increase in scores with age, both total and individual item scores in Duchenne were still far from those obtained in the typically developing children of the same age. Our findings suggest that the North Star Ambulatory Assessment can be reliably used at least from the age of 4 years. Longitudinal natural history data studies are needed to assess possible changes over time and the possible effect of early steroids.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; North Star Ambulatory Assessment; Outcome measure; Typically developing boys

Mesh:

Year:  2014        PMID: 25454732     DOI: 10.1016/j.nmd.2014.09.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.

Authors:  Jacob J Gissy; Teresa Johnson; Deborah J Fox; Anil Kumar; Emma Ciafaloni; Anthonie J van Essen; Holly L Peay; Ann Martin; Ann Lucas; Richard S Finkel
Journal:  Neuromuscul Disord       Date:  2017-07-21       Impact factor: 4.296

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

4.  Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

Authors:  Michela Guglieri; Kate Bushby; Michael P McDermott; Kimberly A Hart; Rabi Tawil; William B Martens; Barbara E Herr; Elaine McColl; Chris Speed; Jennifer Wilkinson; Janbernd Kirschner; Wendy M King; Michelle Eagle; Mary W Brown; Tracey Willis; Robert C Griggs; Volker Straub; Henriette van Ruiten; Anne-Marie Childs; Emma Ciafaloni; Perry B Shieh; Stefan Spinty; Lorenzo Maggi; Giovanni Baranello; Russell J Butterfield; I A Horrocks; Helen Roper; Zoya Alhaswani; Kevin M Flanigan; Nancy L Kuntz; Adnan Manzur; Basil T Darras; Peter B Kang; Leslie Morrison; Monika Krzesniak-Swinarska; Jean K Mah; Tiziana E Mongini; Federica Ricci; Maja von der Hagen; Richard S Finkel; Kathleen O'Reardon; Matthew Wicklund; Ashutosh Kumar; Craig M McDonald; Jay J Han; Nanette Joyce; Erik K Henricson; Ulrike Schara-Schmidt; Andrea Gangfuss; Ekkehard Wilichowski; Richard J Barohn; Jeffrey M Statland; Craig Campbell; Giuseppe Vita; Gian Luca Vita; James F Howard; Imelda Hughes; Hugh J McMillan; Elena Pegoraro; Luca Bello; W Bryan Burnette; Mathula Thangarajh; Taeun Chang
Journal:  JAMA       Date:  2022-04-19       Impact factor: 157.335

Review 5.  Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.

Authors:  Akinori Nakamura
Journal:  J Hum Genet       Date:  2017-06-01       Impact factor: 3.172

6.  Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy.

Authors:  Eugenio Mercuri; Giorgia Coratti; Sonia Messina; Valeria Ricotti; Giovanni Baranello; Adele D'Amico; Maria Carmela Pera; Emilio Albamonte; Serena Sivo; Elena Stacy Mazzone; Maria Teresa Arnoldi; Lavinia Fanelli; Roberto De Sanctis; Domenico M Romeo; Gian Luca Vita; Roberta Battini; Enrico Bertini; Francesco Muntoni; Marika Pane
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

7.  Circulating Biomarkers for Duchenne Muscular Dystrophy.

Authors:  Annemieke Aartsma-Rus; Pietro Spitali
Journal:  J Neuromuscul Dis       Date:  2015-07-22

8.  A video game based hand grip system for measuring muscle force in children.

Authors:  Mark Gotthelf; DeWayne Townsend; William Durfee
Journal:  J Neuroeng Rehabil       Date:  2021-07-10       Impact factor: 4.262

9.  Usefulness of continuous actigraph monitoring in the assessment of the effect of corticosteroid treatment for Duchenne muscular dystrophy: a case report.

Authors:  Hitomi Nishizawa; Naoko Shiba; Akinori Nakamura
Journal:  J Phys Ther Sci       Date:  2016-11-29

10.  Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.

Authors:  Kristin Strandberg; Burcu Ayoglu; Andreas Roos; Mojgan Reza; Erik Niks; Mirko Signorelli; Erik Fasterius; Fredrik Pontén; Hanns Lochmüller; Joana Domingos; Pierpaolo Ala; Francesco Muntoni; Annemieke Aartsma-Rus; Pietro Spitali; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  J Neuromuscul Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.